Increased CXCL12/CXCR4 signaling has been reported after withdrawal of chemotherapy and shown to promote bone marrow derived endothelial progenitor cell mobilization and subsequent tumor homing, leading to an angiogenic rebound and regrowth of tumors [34], [40], [41]. The gene discussed is CXCR4; the disease is neoplasm.